```html

Feline Calicivirus Infection (Human Zoonosis)

Overview

Feline calicivirus (FCV) is a single‑stranded RNA virus that primarily causes upper respiratory disease in cats. In rare cases, the virus can cross the species barrier and infect humans, a phenomenon known as a zoonotic infection. Human FCV infection is extremely uncommon; most reports come from veterinary workers, laboratory personnel, or individuals with prolonged close contact with infected cats.

Who it affects: Healthy adults are the most commonly reported human cases, though immunocompromised people may experience more severe disease. Children, the elderly, and pregnant individuals appear to be at lower risk simply because exposure is less frequent.

Prevalence: According to a 2023 review in the Journal of Medical Virology, fewer than 30 confirmed human FCV cases have been reported worldwide since the virus was first identified in the 1970s. The true incidence is likely lower because many mild infections go undiagnosed.

Although human infection is rare, the potential for zoonotic transmission underscores the importance of good hygiene when handling cats, especially those with respiratory illness.

Symptoms

Human FCV infection typically begins 2‑7 days after exposure and lasts 7‑14 days. Symptoms can range from mild to moderate and may include:

• Fever – low‑grade (37.5‑38.5 °C) or higher, often accompanied by chills.
• Sore throat – scratchy or burning sensation, sometimes with erythema.
• Dry cough – non‑productive, may worsen at night.
• Runny nose (rhinorrhea) – clear to mucoid discharge.
• Conjunctivitis – redness, itching, or tearing of the eyes.
• Headache – pressure‑type, often localized to the forehead.
• Fatigue – generalized weakness and reduced stamina.
• Muscle aches (myalgia) – especially in the neck and back.
• Loss of appetite – may lead to mild weight loss if symptoms persist.
• Oral lesions – occasional small ulcerations on the tongue or buccal mucosa (reported in ~10% of cases).

Most patients recover without complications. However, immunocompromised individuals can develop more severe lower‑respiratory involvement, such as bronchitis or pneumonia.

Causes and Risk Factors

What causes infection?

FCV is shed in the saliva, nasal secretions, and eye discharge of infected cats. Transmission to humans occurs through:

• Direct contact with an infected cat’s mouth or nose (e.g., licking, kissing).
• Handling contaminated bedding, litter, or grooming tools.
• Aerosolized droplets when an infected cat sneezes or coughs.
• Laboratory exposure during virology work (rare).

Who is at higher risk?

• Veterinary staff, shelter workers, and cat breeders.
• People with prolonged close contact with a cat showing signs of FCV (sneezing, nasal discharge).
• Individuals with weakened immune systems (HIV, chemotherapy, organ transplant recipients).
• Those who do not practice proper hand hygiene after handling cats.

Diagnosis

Because human FCV infection mimics common viral upper‑respiratory illnesses, a high index of suspicion is needed, especially after known cat exposure. Diagnostic steps include:

1. Clinical assessment – detailed exposure history and symptom review.
2. Laboratory testing:
   • Reverse transcription polymerase chain reaction (RT‑PCR) of nasopharyngeal swabs – the gold standard for detecting FCV RNA.
   • Viral culture – performed in specialized labs; takes 2‑3 days.
   • Serology – a rise in FCV‑specific IgM/IgG titers between acute and convalescent samples can support the diagnosis.
3. Exclusion of other pathogens – rapid influenza, RSV, and SARS‑CoV‑2 tests are often ordered simultaneously.

According to the CDC, a confirmed case requires a positive RT‑PCR or viral culture from a respiratory specimen, plus compatible clinical symptoms.

Treatment Options

There is no specific antiviral medication approved for human FCV. Management is supportive:

• Hydration – oral fluids or, if unable to maintain intake, intravenous crystalloids.
• Antipyretics/analgesics – acetaminophen or ibuprofen for fever and pain (avoid aspirin in children).
• Cough suppressants – dextromethorphan as needed.
• Topical ocular therapy – lubricating eye drops for conjunctivitis; antibiotics only if bacterial superinfection is suspected.
• Antibiotics – not effective against the virus but may be prescribed if secondary bacterial infection develops (e.g., sinusitis).
• Antiviral research – in vitro studies suggest that ribavirin may inhibit FCV replication, but clinical data are lacking.

Patients with severe respiratory involvement (e.g., pneumonia) may require hospital admission for oxygen therapy, bronchodilators, or even mechanical ventilation.

Living with Feline Calicivirus Infection (Human Zoonosis)

While most people recover fully, the following tips help manage symptoms and prevent spread:

• Rest – aim for 7‑9 hours of sleep per night.
• Stay hydrated – water, herbal teas, and oral rehydration solutions.
• Nutrition – soft, easy‑to‑swallow foods (soups, smoothies, yogurt) if sore throat is significant.
• Humidified air – a cool‑mist humidifier can ease cough and nasal congestion.
• Hand hygiene – wash hands with soap for at least 20 seconds after any contact with cats or their environment.
• Isolate the infected cat – keep it in a separate room, use dedicated litter boxes, and wear gloves when handling.
• Monitor symptoms – keep a daily log of temperature, cough frequency, and any new signs (e.g., shortness of breath).
• Follow‑up – schedule a post‑infection visit with your clinician to ensure complete resolution, especially if you are immunocompromised.

Prevention

Because human infection is linked to cat exposure, prevention focuses on reducing cat‑to‑human viral transmission:

• Vaccinate cats – the core feline vaccine includes FCV; vaccinated cats have lower viral shedding. (Source: American Veterinary Medical Association)
• Routine veterinary care – prompt diagnosis and isolation of sick cats reduces environmental contamination.
• Hand washing – soap and water or an alcohol‑based hand sanitizer after petting, feeding, or cleaning litter boxes.
• Use personal protective equipment (PPE) – gloves and surgical masks when handling cats with respiratory signs, especially for veterinary staff.
• Environmental cleaning – disinfect surfaces with a 1:32 bleach solution or EPA‑registered disinfectants effective against non‑enveloped viruses.
• Avoid face‑touching – especially after interacting with cats.
• Limit exposure for high‑risk individuals – immunocompromised persons should avoid close contact with sick cats.

Complications

Most infections are self‑limited, but complications can arise, particularly in vulnerable populations:

• Secondary bacterial sinusitis or otitis media – may require antibiotics.
• Pneumonia – viral bronchitis can progress to lower‑respiratory infection, needing hospital care.
• Exacerbation of asthma or chronic obstructive pulmonary disease (COPD) – viral inflammation can trigger attacks.
• Prolonged viral shedding – immunocompromised patients may continue to shed virus for weeks, increasing transmission risk.
• Rare systemic involvement – case reports describe mild hepatitis and encephalitis, though causality is uncertain.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, Journal of Medical Virology 2023, American Veterinary Medical Association.

```